Biochemical analysis demonstrated that enzastaurin inhibits the expression of pAkt in all of the cancer cell lines examined and suppresses the expression and secretion of VEGF, especially in those cell lines resistant to EGFR inhibitors. This evidence concerns the gene EGFR and cancer.